Description
Ezetimibe research compound
Ezetimibe inhibits intestinal cholesterol absorption by blocking the NPC1L1 transporter.
Product details
| Compound | Ezetimibe |
|---|---|
| Class | Cholesterol absorption inhibitor |
| Format | See product label |
| Labelling | Compound name and strength on every container |
What research has examined
- NPC1L1 research: intestinal cholesterol uptake.
- Lipid metabolism: combination with statins.
- Enterohepatic research.
Research interest does not establish a proven effect in humans.
Regulatory status
Licensed medicines containing this active ingredient are prescription-only products made by authorised manufacturers. The material sold here is a research chemical, not a licensed medicine, and is not approved for any use in humans.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.